Lactate Accumulation in CHO Culture: Causes, Effects & Solutions

By BioProcess Tools Team | March 26, 2026 | 10 min read | Last updated: March 2026

1. Why Lactate Matters

Lactate is the most common metabolic waste product in CHO cell culture, and it is one of the most reliable indicators that something is going wrong with your process. When CHO cells consume glucose, a significant fraction of it is converted to lactate rather than being fully oxidized through the TCA cycle—even when oxygen is plentiful. This phenomenon, known as the Warburg effect or aerobic glycolysis, is a hallmark of rapidly proliferating mammalian cells.

The consequences of unchecked lactate accumulation are severe and interconnected. At concentrations above 4 g/L, lactate begins to measurably inhibit cell growth and reduce specific productivity. The mechanism is twofold: lactate itself is mildly cytotoxic, and its accumulation drives the culture pH downward, forcing increased base addition (typically NaOH or Na2CO3). This base addition raises osmolality—which at levels above 400 mOsm/kg further stresses cells and reduces viability.

The Lactate Cascade

High lactate → low pH → base addition → high osmolality → reduced viability → lower titer. This cascade is the single most common failure mode in poorly optimized CHO fed-batch processes. Addressing lactate at the source breaks the entire chain.

Beyond growth inhibition, lactate accumulation signals metabolic inefficiency. Every molecule of glucose converted to lactate yields only 2 ATP, compared to 36 ATP from complete oxidation. Cells that produce excessive lactate are wasting carbon that could otherwise be directed toward biomass growth and recombinant protein production. Understanding and controlling lactate is therefore not just about avoiding toxicity—it is about fundamentally improving the metabolic efficiency of your process.

2. Lactate Metabolism in CHO Cells

The pathway from glucose to lactate is straightforward: glucose enters the cell via GLUT transporters, is phosphorylated to glucose-6-phosphate, and proceeds through glycolysis to produce two molecules of pyruvate. In cells with fully active mitochondrial respiration, pyruvate would enter the TCA cycle via pyruvate dehydrogenase (PDH). But in CHO cells—and most cancer-derived mammalian cell lines—a large fraction of pyruvate is instead reduced to lactate by lactate dehydrogenase (LDH).

Glucose → 2 Pyruvate + 2 ATP + 2 NADH

Then either:
Pyruvate → Acetyl-CoA → TCA cycle (+34 ATP, efficient)
Pyruvate + NADH → Lactate + NAD+ (wasteful, regenerates NAD+)

The LDH reaction regenerates NAD+, which is essential for glycolysis to continue. When glycolytic flux is high—as it is when glucose is abundant—the mitochondria cannot process pyruvate fast enough, and LDH provides a relief valve by converting the excess pyruvate to lactate. The lactate is then exported from the cell via MCT (monocarboxylate transporter) proteins, acidifying the culture medium.

Critically, CHO cells are not locked into lactate production. Under the right conditions, many CHO cell lines can reverse the LDH reaction and consume lactate as a carbon source. This metabolic reversal—the so-called "metabolic shift"—is one of the most important phenomena in CHO fed-batch culture and is the foundation of modern feeding strategies.

Glutamine and Lactate

Glucose is not the only source of lactate. Glutamine—the most abundant amino acid in most CHO media—is metabolized through glutaminolysis, which converts glutamine to glutamate and then to α-ketoglutarate for TCA cycle entry. This pathway also generates lactate as a byproduct, along with ammonia (another toxic waste product). A CHO culture consuming both excess glucose and excess glutamine can produce lactate at alarming rates.

3. Causes of High Lactate

Lactate accumulation in CHO culture is almost always caused by one or more of the following factors. Understanding which one is dominant in your process is the key to selecting the right solution.

Excess Glucose (>4 g/L)

This is the most common cause. When extracellular glucose exceeds approximately 4 g/L, CHO cells engage in overflow metabolism—glucose uptake outpaces mitochondrial capacity, and the excess pyruvate is shunted to lactate. The relationship is roughly linear: above the threshold, specific lactate production rate (qLac) increases proportionally with glucose concentration. At 8–10 g/L glucose, CHO cells may convert 70–90% of consumed glucose to lactate.

Excess Glutamine

Glutamine concentrations above 4 mM drive glutaminolysis, generating both lactate and ammonia. The combined effect of these two waste products is particularly damaging because ammonia inhibits glycosylation—directly impacting product quality. Many modern CHO media have moved to lower glutamine concentrations (2 mM or less) or replaced free glutamine entirely with dipeptide alternatives.

Low Culture pH (<6.8)

Acidic conditions increase LDH activity and shift the pyruvate–lactate equilibrium toward lactate production. This creates a vicious cycle: lactate lowers pH, which increases LDH activity, which produces more lactate. If pH control is sluggish or if the base addition rate is insufficient, the culture can spiral into an acidotic state.

High Specific Growth Rate

Rapidly dividing cells have higher glycolytic flux. During the exponential growth phase (days 1–4 of a typical fed-batch), lactate production rates are highest. This is normal and expected—the problem arises when lactate production does not taper off as growth slows.

Insufficient Dissolved Oxygen

When DO drops below 20% air saturation, mitochondrial respiration is compromised and cells shift toward anaerobic glycolysis. This drives pyruvate toward lactate. While modern bioreactors rarely have sustained DO limitation, transient oxygen depletion can occur during high-density culture or after large feed additions. See our guide on dissolved oxygen control in CHO culture for more detail.

4. The Metabolic Shift

One of the most remarkable features of CHO cell metabolism is the ability to switch from lactate production to lactate consumption during a fed-batch culture. This metabolic shift typically occurs between days 4 and 7 and is characterized by a reversal in the net lactate profile: after rising during the growth phase, lactate concentration plateaus and then actively declines.

CHO Metabolic Switch Diagram Two metabolic states shown side by side. Left: Glycolytic state where glucose is converted to pyruvate and then to lactate via LDH, with lactate accumulating. Right: Oxidative state where glucose is converted to pyruvate and then enters the TCA cycle via PDH, producing CO2 and ATP while lactate is consumed. A switching arrow between them shows the metabolic shift triggered by lower glucose, temperature shift, and media optimization. The Metabolic Switch Glycolytic State Glucose Pyruvate LDH Lactate Accumulates ↑ pH drops Oxidative State Glucose Pyruvate PDH TCA Cycle CO₂ ATP Lactate consumed ↓ METABOLIC SHIFT Lower glucose Temp shift Media optimization
Figure: The metabolic switch in CHO cells. In the glycolytic state (left), excess glucose drives pyruvate to lactate via LDH. In the oxidative state (right), reduced glucose allows pyruvate to enter the TCA cycle via PDH, and lactate is consumed as fuel.
Key Insight

The metabolic shift is not just a curiosity—it is the hallmark of a well-optimized CHO fed-batch process. Cultures that achieve a strong metabolic shift consistently deliver higher titers, better viability at harvest, and improved product quality compared to cultures that produce lactate throughout.

The shift is triggered primarily by glucose limitation. When extracellular glucose drops below approximately 1–2 g/L, the glycolytic flux slows and the mitochondria can process the reduced pyruvate load. With less pyruvate available, the LDH equilibrium reverses: lactate is now oxidized back to pyruvate and fed into the TCA cycle. The cell effectively uses its own accumulated waste as fuel.

Several factors promote a robust metabolic shift:

Not all CHO cell lines shift equally. Some clones are "metabolic shift competent" while others remain persistent lactate producers. Clone selection should include metabolic profiling alongside titer and growth rate assessments. A clone that grows slightly slower but shifts early may outperform a fast-growing clone that never shifts.

5. Solutions & Mitigation Strategies

Glucose-Limited Feeding (Most Effective)

The most impactful intervention is to limit glucose availability. Rather than bolus-feeding glucose to maintain 4–6 g/L (as is common in basic protocols), use a glucose-limited strategy that maintains residual glucose between 0.5 and 2 g/L. This can be achieved through:

The tradeoff is operational complexity. A glucose-limited strategy requires more frequent sampling or online monitoring and tighter process control. But the payoff is dramatic—lactate reductions of 60–80% are typical.

Design Your Feeding Strategy

Use our Fed-Batch Calculator to model glucose-limited feeding profiles and predict lactate accumulation.

Fed-Batch Calculator →

Replace Glutamine with GlutaMAX

GlutaMAX (L-alanyl-L-glutamine) is a dipeptide that is slowly hydrolyzed by cellular peptidases, releasing glutamine at a controlled rate. This prevents the glutamine spike that drives glutaminolysis. Replacing 4–8 mM free glutamine with an equimolar amount of GlutaMAX typically reduces both lactate and ammonia accumulation by 30–50%, with no negative impact on growth or productivity.

Temperature Shift to 33°C

Reducing culture temperature from 37°C to 31–33°C on day 3–5 (after the exponential growth phase) has multiple benefits: it slows metabolic rate, reduces glucose consumption, promotes the metabolic shift, extends viability, and in many cases increases specific productivity (qP). The "biphasic" temperature strategy—37°C for growth, 33°C for production—is now standard in the majority of commercial CHO processes.

Higher pH Setpoint (7.0–7.1)

Raising the pH setpoint from the typical 6.9 to 7.0–7.1 during the production phase reduces LDH activity and favors lactate consumption. This approach is simple to implement but must be balanced against the risk of increased aggregation at higher pH.

Pyruvate Supplementation

Adding sodium pyruvate (1–5 mM) to the culture or feed shifts the LDH equilibrium away from lactate production by increasing the pyruvate:lactate ratio. This strategy works best in combination with glucose-limited feeding.

Media Optimization

Several proprietary chemically defined feeds (from Cytiva, Merck, Thermo Fisher, and others) have been specifically formulated to minimize lactate accumulation. These feeds typically feature lower glucose and glutamine concentrations, elevated pyruvate, and optimized amino acid ratios. Evaluating 3–5 commercial feed systems in small-scale experiments is a standard part of process development.

6. Monitoring Lactate in Real Time

You cannot manage what you do not measure. Lactate monitoring is essential for process understanding and for implementing glucose-limited feeding strategies. The main options are:

Method Frequency Typical Instruments
At-line analyzers Every 12–24h (manual sampling) BioProfile FLEX2, Cedex Bio HT, Vi-CELL MetaFLEX
Online sensors Continuous (every 5–15 min) Raman spectroscopy (Kaiser, Endress+Hauser), NIR probes
Offline laboratory Daily (send to QC lab) YSI 2900, enzymatic assay kits

Raman-based inline monitoring has become increasingly popular because it enables real-time lactate measurement without sampling. When coupled with a feedback control system, Raman can drive automated glucose feeding to maintain lactate below a target threshold—a true closed-loop PAT (Process Analytical Technology) approach.

7. Case Study: Fed-Batch Rescue

A CHO-K1 derived clone producing an IgG1 monoclonal antibody was run in a 5 L bioreactor with a standard bolus feeding protocol: glucose maintained at 4–6 g/L by daily bolus addition of 400 g/L glucose stock, glutamine at 4 mM, temperature constant at 37°C.

The Problem

Day 3: Lactate = 2.8 g/L VCD = 6.2 × 106 cells/mL Viability = 97% Day 5: Lactate = 5.2 g/L VCD = 10.1 × 106 cells/mL Viability = 91% Day 7: Lactate = 5.8 g/L VCD = 8.4 × 106 cells/mL Viability = 78% Day 10: Lactate = 4.9 g/L VCD = 5.1 × 106 cells/mL Viability = 62% Osmolality reached 420 mOsm/kg by day 7 (NaOH additions) Final titer: 1.2 g/L at harvest (day 12)

Lactate peaked at 5.2 g/L on day 5, driving a pH crash that required aggressive base addition. The resulting osmolality spike caused a viability collapse. The culture had to be harvested early with a disappointing titer.

The Solution

Three changes were implemented simultaneously:

  1. Glucose-limited bolus feeding: Glucose targeted at 1–2 g/L with twice-daily boluses based on BioProfile FLEX2 measurements.
  2. GlutaMAX: Free glutamine replaced with 6 mM GlutaMAX.
  3. Temperature shift: 37°C → 33°C on day 4.
Day 3: Lactate = 1.8 g/L VCD = 5.8 × 106 cells/mL Viability = 98% Day 5: Lactate = 1.4 g/L VCD = 11.2 × 106 cells/mL Viability = 96% Day 7: Lactate = 0.8 g/L VCD = 12.8 × 106 cells/mL Viability = 93% Day 10: Lactate = 0.3 g/L VCD = 10.5 × 106 cells/mL Viability = 88% Day 14: Lactate = 0.2 g/L VCD = 7.2 × 106 cells/mL Viability = 85% Osmolality stayed below 340 mOsm/kg throughout Final titer: 3.1 g/L at harvest (day 14) — 2.6× improvement

The metabolic shift occurred on day 4–5, with lactate actively consumed thereafter. Viability remained above 85% at harvest on day 14, extending the production window by two full days. Final titer increased from 1.2 g/L to 3.1 g/L—a 2.6-fold improvement from three simple process changes.

🔍

Troubleshoot Your CHO Process

Diagnose lactate, ammonia, osmolality, and other common CHO culture issues with our interactive troubleshooter.

CHO Troubleshooter →

References

  1. Zagari, F., Jordan, M., Stettler, M., Broly, H., & Wurm, F.M. (2013). "Lactate metabolism shift in CHO cell culture: the role of mitochondrial oxidative activity." New Biotechnology, 30(2), 238–245. doi:10.1016/j.nbt.2012.05.021
  2. Templeton, N., Dean, J., Reddy, P., & Young, J.D. (2013). "Peak antibody production is associated with increased oxidative metabolism in an industrially relevant fed-batch CHO cell culture." Biotechnology and Bioengineering, 110(7), 2013–2024. doi:10.1002/bit.24858
  3. Luo, J., Vijayasankaran, N., Autsen, J., et al. (2012). "Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process." Biotechnology and Bioengineering, 109(1), 146–156.
  4. Pereira, S., Kildegaard, H.F., & Andersen, M.R. (2018). "Impact of CHO Metabolism on Cell Growth and Protein Production: An Overview of Toxic and Inhibiting Metabolites and Nutrients." Biotechnology Journal, 13(3), 1700499.

📚 Resources & Further Reading

Stay updated on bioprocess tools

Get notified when we publish new articles, calculators, and reference guides for fermentation & cell culture engineers.

Free forever · No spam · Unsubscribe anytime